CN105802970A - ShRNA of target-silenced GBeta1 - Google Patents

ShRNA of target-silenced GBeta1 Download PDF

Info

Publication number
CN105802970A
CN105802970A CN201610361175.4A CN201610361175A CN105802970A CN 105802970 A CN105802970 A CN 105802970A CN 201610361175 A CN201610361175 A CN 201610361175A CN 105802970 A CN105802970 A CN 105802970A
Authority
CN
China
Prior art keywords
shrna
gbeta1
support
fragments
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610361175.4A
Other languages
Chinese (zh)
Inventor
何潇潇
朱筱娟
郭野
赵璐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeastern University China
Northeast Normal University
Original Assignee
Northeast Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeast Normal University filed Critical Northeast Normal University
Priority to CN201610361175.4A priority Critical patent/CN105802970A/en
Publication of CN105802970A publication Critical patent/CN105802970A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention belongs to the technical field of DNA recombination in biological engineering and particularly relates to shRNA of specific-silenced target protein GBeta1. A silencing support of GBeta1 is constructed herein. Firstly, shRNA fragments of 19 bp are designed according to GBeta1 sequence of mouse origin, two ends of the synthesized fragments are provided with suitable restriction enzyme cutting sites, a target fragment is connected to pSUPER support to form a core silencing support, and a male clone is selected for PCR (polymerase chain reaction) verification after transformation. A correct support is verified for DNA sequencing. Then, silencing efficiency is detected through immunoblotting test. Two shRNA fragments capable of targeting at 19 bp of mouse origin GBeta1 are synthesized and designed herein, and the shRNA fragments include GCATCTGGCAAAGATTTAT and GGATGACAATCAGATAGTT.

Description

The shRNA of targeted silent G β 1
Technical field
The invention belongs to the DNA recombinant technique field in biological engineering, be specifically related to the shRNA of specificity silence target proteins G β 1.
Background technology
G-protein β subunit 1(Gprotein β subunit1, G β 1) by Gnb1 gene code, it is the important component part of heterotrimeric G protein, it is possible to and forming dimer with G γ subunit, the common extracellular signal that participates in is at intracellular transductive process.G β 1 is formed seven WDdomain repeated by 340 amino acid residues, and protein sequence forms propeller-type structure after space folding.Due to the wide spectrum expression characterization of G β 1, many researchs about G β γ are all with G β 1 representatively property analysis.Research report proves that G β 1 can participate in the various kinds of cell biological event such as the formation of spindle axis in mitosis process, the migration of neutrophilic granulocyte, cell chemotaxis
The function of the G β γ subunit that G β 1 participates in composition has broad spectrum activity and representativeness, is the one studying the most general G β subunit.Recent studies indicate that, G β 1 can participate in the chemotactic of cell, can regulate formation and the motion transition process of spindle axis in ontogenetic process simultaneously, embryo's ontogeny is had important effect.So the careful accurate functional study in ontogenetic process and mechanism analysis can be played most important by specific reticent G β 1.
Summary of the invention
It is an object of the invention to synthesize specifically can the specific base sequence of targeted silent G β 1, provide effective means for more deep research G β 1 and its effect in cell signalling and cell movement.
What mainly build required in the present invention is the silent carrier of G β 1.Core silent carrier builds and is divided into two big steps, first it is the shRNA fragment that goes out 19bp of G β 1 sequential design according to Mus source, synthesized fragment two ends are with suitable restriction enzyme site, purpose fragment is connected on pSUPER carrier, form the silent carrier of core, after conversion, picking positive colony carries out PCR qualification.Identify correct carrier, carry out DNA sequencing, carried out the detection of silence efficiency subsequently by immunoblotting analysis experiment.
In the present invention, design has synthesized two can shRNA, the shRNA sequence of 19bp of targeted mouse source G β 1 be GCATCTGGCAAAGATTTAT and GGATGACAATCAGATAGTT
Can the structure of expression vector of specificity silence G β 1 comprise the following steps:
The first step, shRNA fragment sequence designs
The sequence of corresponding software design specific recognition G β 1 is applied according to Mus source G β 1 gene order.
Second step, the synthetic of double-strand shRNA fragment
The two of synthetic Sense and Antisense are formed double-stranded DNA by degeneration, annealing.
3rd step, the structure of silent carrier
After silent carrier pSUPER double digestion, utilize and reclaim test kit recovery linearized vector, be attached reclaiming the fragment shRNA fragment with annealing gained, convert, identify that positive colony, order-checking obtain the silent carrier successfully constructed.
4th step, the detection of reticent target protein efficiency
Extract plasmid, extract albumen after transfectional cell, utilize immune-blotting method silence efficiency.
Accompanying drawing illustrates:
Fig. 1: pSUPER carrier double digestion gel electrophoresis figure;
Fig. 2: bacterium solution PCR result gel electrophoresis figure, 1-5 is that G β 1shRNA159 identifies clone, and 8-12 is that G β 1shRNA456 identifies clone, is positive findings in white box;
Fig. 3: WesternBlot silence efficiency testing result.
The present invention designs the shRNA fragment of the 19bp of synthesis, it is possible to specific reticent G β 1, G β 1 is the important component part of trimer G-protein.Showing after deliberation, G β 1 plays an important role in ontogeny and cell movement process, the carrier successfully constructed, it is possible to specific reticent G β 1, reduces the expression of G β 1 in cell.Therefore, its function in ontogeny cell movement process of research that the application of G β 1 silent carrier can be more fine, for explaining that related mechanism is provided fundamental basis.
Detailed description of the invention:
Embodiment one: the expression vector establishment of specificity silence target proteins G β 1
1, the sequential design of specificity silence target protein G β 1
(1) designing silencing sequence according to Mus source G β 1 gene expression characteristics, the G/C content of the sequence of the specific binding G β 1 of the principle of design: 19bp is 45%-55%, annealing temperature 45 DEG C-65 DEG C, and first base simultaneously requiring sequence initial is G.The fragment chosen is carried out BLAST human genome comparison, selects specific sequence.
(2) synthesizing one section of 59bp sequence with Bgl II-GN18-TT-loop-81NC-Hind III form, 81NC is the reverse complemental of NG18, and 5 ' ends are Bgl II restriction enzyme site, and 3 ' ends are Hind III restriction enzyme site.The cDNA sequence 159-177(G β 1shRNA159 of the fragment of design synthesis targeting G β 1 respectively) and 456-474(G β 1shRNA456)
2, the synthesis of the shRNA sequence of targeted silent G β 1 and storage
(1) two sections of oligo of synthesis are dissolved to 50 μMs, respectively take 10 μ l mixing.
(2) 95 DEG C of degeneration 5min, hatch 10min for 72 DEG C, close PCR instrument.
(3) take out mixing, be placed on standby on ice, or-20 DEG C long-term preservations.
3, the structure of silent carrier pSUPER-G β 1
(1) take 2 μ gpSUPER carriers, Bgl II and Hind III double digestion, electrophoresis, reclaim linear pSUPER large fragment [Fig. 1]
(2) connect and convert.By linearisation pSUPER concentration dilution to 100ng/ μ, coupled reaction (the T4DNA ligase of Promege company)
4 DEG C overnight connect, and will connect product and convert DH5 α competent cell, and be coated on the LB flat board with Kan resistance.
(3) positive clone identification.Shaking bacterium converting picking monoclonal on flat board, test kit extracts plasmid, identifies positive colony [Fig. 2] by PCR.Identify that primer is pSUPERtest-P1:5 '-gcgtgaattcgaacgctgac-3 ', pSUPERtest-R:5 ' gaattttaacaaaatattaacgctt-3 '.With pSUPERtest-P1 for sequencing primer, send Beijing Hua Da gene sequencing.
Embodiment two:
The detection of reticent target protein efficiency
(1) control and G β 1shRNAs is entered NLT cell by electrotransfection
(2) extracting total protein of cell, utilize Westernblot immunoblotting assay, after proceeding to G β 1 silent carrier, G β 1 expression significantly reduces, and α-Tubulin is internal reference [Fig. 3].
Sequence table
<110>Northeast Normal University
<120>shRNA of targeted silent G β 1
<141>2015-01-15
<160>19
<210>2
<211>19
<212>
<213>artificial sequence
<220>
<221>misc_RNA
<222>(1)...(19)
<223>
<400>1
GCATCTGGCAAAGATTTAT and GGATGACAATCAGATAGTT.

Claims (1)

1. the shRNA of targeted silent G β 1, is characterized in that shRNA sequence is GCATCTGGCAAAGATTTAT and GGATGACAATCAGATAGTT.
CN201610361175.4A 2016-05-30 2016-05-30 ShRNA of target-silenced GBeta1 Pending CN105802970A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610361175.4A CN105802970A (en) 2016-05-30 2016-05-30 ShRNA of target-silenced GBeta1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610361175.4A CN105802970A (en) 2016-05-30 2016-05-30 ShRNA of target-silenced GBeta1

Publications (1)

Publication Number Publication Date
CN105802970A true CN105802970A (en) 2016-07-27

Family

ID=56452038

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610361175.4A Pending CN105802970A (en) 2016-05-30 2016-05-30 ShRNA of target-silenced GBeta1

Country Status (1)

Country Link
CN (1) CN105802970A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1320610A (en) * 2000-04-27 2001-11-07 上海博德基因开发有限公司 Polypeptide-G-beta similar protein 29 and polynucleotide for coding it
CN1342664A (en) * 2000-09-12 2002-04-03 上海博德基因开发有限公司 Polypeptide-G-beta protein 14.08 containing WD duplicate domain and polynucleotide for coding it
WO2005116204A1 (en) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
WO2007102872A2 (en) * 2005-12-16 2007-09-13 The Uab Research Foundation Compositions and methods related to controlled gene expression using viral vectors
CN101171022A (en) * 2005-03-07 2008-04-30 罗彻斯特大学 Compositions and methods for inhibiting G protein signaling
CN102834114A (en) * 2010-04-13 2012-12-19 米迪缪尼有限公司 Fibronectin type iii domain-based multimeric scaffolds
CN104053667A (en) * 2011-06-21 2014-09-17 非营利性组织佛兰芒综合大学生物技术研究所 Binding Domains Directed Against Gpcr:G Protein Complexes And Uses Derived Thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1320610A (en) * 2000-04-27 2001-11-07 上海博德基因开发有限公司 Polypeptide-G-beta similar protein 29 and polynucleotide for coding it
CN1342664A (en) * 2000-09-12 2002-04-03 上海博德基因开发有限公司 Polypeptide-G-beta protein 14.08 containing WD duplicate domain and polynucleotide for coding it
WO2005116204A1 (en) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
CN101052717A (en) * 2004-05-11 2007-10-10 α基因株式会社 Polynucleotide causing RNA interfere and method of regulating gene expression with the use of the same
CN101171022A (en) * 2005-03-07 2008-04-30 罗彻斯特大学 Compositions and methods for inhibiting G protein signaling
WO2007102872A2 (en) * 2005-12-16 2007-09-13 The Uab Research Foundation Compositions and methods related to controlled gene expression using viral vectors
CN102834114A (en) * 2010-04-13 2012-12-19 米迪缪尼有限公司 Fibronectin type iii domain-based multimeric scaffolds
CN104053667A (en) * 2011-06-21 2014-09-17 非营利性组织佛兰芒综合大学生物技术研究所 Binding Domains Directed Against Gpcr:G Protein Complexes And Uses Derived Thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HONGJIE CHEN ET AL.: "Insulin Signaling in Vascular Endothelial Cells: A Key Role for Heterotrimeric G Proteins Revealed by siRNA-Mediated Gβ1 Knockdown", 《BIOCHEMISTRY》 *
MCFARLANE-ANDERSON ET AL.: "M. musculaus mRNA for G-protein beta-subunit", 《GENBANK》 *
NAITO,Y. ET AL.: "WO 2005116204-A/586075:Double strand polynucleoties generating RNA interference", 《GENBANK》 *

Similar Documents

Publication Publication Date Title
Christin et al. Molecular dating, evolutionary rates, and the age of the grasses
WO2008140615A3 (en) Modified messenger rna stabilizing sequences for expressing genes in bacterial cells
Carretero-Paulet et al. High gene family turnover rates and gene space adaptation in the compact genome of the carnivorous plant Utricularia gibba
WO2007017229A3 (en) Method for carrying out the selective evolution of proteins in vitro
ZA200800517B (en) Transplastomic plants expressing lumen-targeted protein
JP2010501170A (en) Matrix attachment region (MAR) and its use to increase transcription
CN114438055B (en) Novel CRISPR enzymes and systems and uses
Kalunke et al. Reduction of allergenic potential in bread wheat RNAi transgenic lines silenced for CM3, CM16 and 0.28 ATI genes
CN104630247A (en) Insect chitin deacetylate enzyme genes 1 and application of insect chitin deacetylate enzyme genes 1 in pest control
DE602005017034D1 (en) SIGNAL PEPTIDE FOR PREPARING A POLYPEPTIDE
SA112340163B1 (en) Method and construct for synthetic bidirectional SCBV plant promoter
CN105802970A (en) ShRNA of target-silenced GBeta1
CN103667344B (en) A kind of method for activating erythropoietin gene expression
Stadler Class-specific prediction of ncRNAs
WO2003048325A3 (en) Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology
MX2012002187A (en) Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake.
CN105647885B (en) Cas9 fusion proteins and its coded sequence
CN107090509A (en) A kind of recognition methods of competitive endogenous RNA network
CN104004765B (en) A kind of gene with immune effect
CN105907759A (en) shRNA of targeted silent G beta2
CN105925578A (en) Targeted silence Neogenin shRNA
Garmire et al. Regulatory network of microRNAs in RAW 264.7 macrophage cells
Akkuratov et al. Bioinformatics analysis of plant orthologous introns: identification of an intronic tRNA-like sequence
CN105907760A (en) shRNA for targeted silencing of TKS4
Ko et al. Wheat (Triticum aestivum L.) TaHMW1D transcript variants are highly expressed in response to heat stress and in grains located in distal part of the spike

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160727

WD01 Invention patent application deemed withdrawn after publication